Immunotherapy has revolutionized the treatment of patients with cancer. However,
promoting antitumour immunity in patients with tumours that are resistant to these therapies …

The gold drugs, gold sodium thiomalate (Myocrisin), aurothioglucose (Solganal), and the
orally administered auranofin (Ridaura), are utilized in modern medicine for the treatment of …

Immunogenic cell death (ICD) has aroused widespread attention because it can reconstruct
a tumor microenvironment and activate antitumor immunity. This study proposes a two‐way …

The potential of the cluster regularly interspaced short palindromic repeat (CRISPR)‐
associated protein 9 (Cas9)‐based therapeutic genome editing is severely hampered by the …

Induction of immunogenic cell death (ICD) in tumor combined with immune checkpoint
blockade (ICB) therapy is widely developed to improve the efficacy of cancer …

Lung metastasis is challenging in patients with triple‐negative breast cancer (TNBC).
Surgery is always not available due to the dissemination of metastatic foci and most drugs …

Rapid advancements in materials science and nanotechnology, intertwined with oncology,
have positioned photothermal therapy (PTT) as a promising noninvasive treatment strategy …

The combination of immunogenic cell death (ICD) induction and immune checkpoint
blockade has emerged as a major direction of cancer immunotherapy. Among currently …

The immunotherapy efficiency of stimulator of interferon genes (STING)-activatable drugs
(eg, 7-ethyl-10-hydroxycamptothecin, SN38) is limited by their non-specificity to tumor cells …

Although photothermal immunotherapy (PTI) is a compelling strategy for tumor therapy, the
development of promising photothermal agents to overcome the insufficient immunogenicity …